1[1]Brown DR, Schroeder JM, Fife KH, et al. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol, 1999, 37(10):3316-3322
2[2]Bauer HM, Ting Y, Manos MM, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA, 1991, 265(4):472-477
3[3]Bernard HU, Chan SY, Wheeler CM, et al. Identification and assessment of known and novel human papilomaviruses by PCR amplification, restriction fragment length polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis, 1994, 170:1077-1085
4[4]Lungu O, Wright TC, Silverstein S. Typing of human papillomaviruses by PCR amplification with L1 consensus primers and RFLP analysis. Mol Cel Probe, 1992, 6:145-152
5[5]Christensen ND, Kirnbauer R, Kreider JW, et al. Human papillomavirus type 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology, 1994, 205:329-335
6[1]Urumoto H, Irahara M. Human papilloma vires (HPV) and cervical cancer. J Med Invest,2002,49(3～4):124
7[2]Sagae S, Kudo R, Kuzumaki N, et al. Ras oncogene expression and progressionin in intraepithelial neolasia of the uterine cervix. Cancer,1990,66:295
8[3]Mazurek S, Zwerschke W, Jansela-Durr P, et al. Metabolic cooperation between different oncogenes during cell transformation:interaction between activated ras and HPV-16 E7. Oncogene, 2001,20(47):6891
9[4]Nair SA, Nair MB, Jayaprakash PG, et al. ras and c-myc oncoproteins during tumor progression in the uterine cervix. Tumori,1998,84(5):583
10[5]Iwasaka T. Detection of human papillomavims genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas. Gynecol Oncol, 1992,46:298
